What's new

Human medicines European public assessment report (EPAR): Omlyclo, omalizumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Omlyclo, omalizumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised

Feb 27, 2025 - 14:05
 0
Human medicines European public assessment report (EPAR): Omlyclo, omalizumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Omlyclo, omalizumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Siemens Mobility advances net zero goals at Goole Rail Village

Next Article

Walgreens Boots buyout to lay groundwork for three-way split of group

Related Posts

EMEA-002713-PIP02-21-M01

EMEA-002713-PIP02-21-M01

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

European Medicines Agency pre-authorisation procedural ...

Feb 24, 2025  0